AI assistant
Sending…
HARVARD BIOSCIENCE INC — Director's Dealing 2012
Jun 4, 2012
34975_dirs_2012-06-04_d7917bbb-34fc-4465-a05a-28ac754052c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2012-06-04
Reporting Person: LEWIS EARL R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-01 | Common Stock | A | 8403 | — | Acquired | 78403 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-01 | Stock option (right to buy) | $3.57 | A | 16100 | Acquired | 2022-06-01 | Common Stock, par value $0.01 per share (16100) | Direct |
Footnotes
F1: Includes (a) a deferred stock award of 8,403 restricted stock units which vest in equal installments on June 1, 2013; June 1, 2014 and June 1, 2015; and (b) 70,000 shares of common stock held by Mr. Lewis.
F2: The options vest in three equal installments on June 1, 2013, 2014 and 2015.
More from HARVARD BIOSCIENCE INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 23
Major Shareholding Notification
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17